Evanston Northwestern Healthcare Evanston Hospital — Evanston, Illinois

Evanston Northwestern Healthcare Evanston Hospital is a clinical research site located in Evanston, Illinois, United States 60201-1781.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

Evanston Northwestern Healthcare Evanston Hospital has participated in 25 clinical trials.

Therapeutic areas: Ovarian Cancer, Excessive Daytime Sleepiness, Narcolepsy.

Sponsors: Gynecologic Oncology Group, Cephalon, Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Evanston

Browse all research sites in Illinois · View every site in Evanston

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Evanston Northwestern Healthcare Evanston Hospital?

Evanston Northwestern Healthcare Evanston Hospital has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Evanston Northwestern Healthcare Evanston Hospital conducted?

Evanston Northwestern Healthcare Evanston Hospital has 25 clinical trials on record. Their work covers Ovarian Cancer, Excessive Daytime Sleepiness, Narcolepsy.

Is Evanston Northwestern Healthcare Evanston Hospital accredited by Crixeo Clinical Trials?

Evanston Northwestern Healthcare Evanston Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Evanston Northwestern Healthcare Evanston Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.